Swayampakula Ramakanth

Stock Analyst at HC Wainwright & Co.

(0.01)
# 1983
Out of 5,291 analysts
596
Total ratings
28.11%
Success rate
-12.97%
Average return
90 Stocks
Name Action Price Target Current % Upside Ratings Updated
Innate Pharma
Reiterates: Buy
12 12
1.98 480.81% 15 Mar 28, 2025
Edap TMS
Reiterates: Buy
19 19
2.12 796.23% 14 Mar 28, 2025
RenovoRx
Initiates Coverage On: Buy
3
1 200% 1 Mar 27, 2025
Leap Therapeutics
Reiterates: Neutral
n/a
n/a n/a 15 Mar 27, 2025
X4 Pharmaceuticals
Reiterates: Buy
2 2
0.26 476.92% 15 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 13
0.77 1588.31% 11 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 1
0.26 284.62% 9 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
15.98 56.45% 18 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
1.58 279.75% 10 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
2.71 158.3% 14 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.06 371.7% 8 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
33 33
13.05 152.87% 7 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
1.1 218.18% 3 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
7.9 153.16% 1 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 6
0.2 2900% 15 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
0.39 1694.87% 9 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
25 25
6.5 284.62% 13 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40 40
19.91 100.9% 5 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
1.79 626.26% 7 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 24
13.13 82.79% 12 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
0.66 657.58% 14 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
0.8 900% 20 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
46 46
6.32 627.85% 11 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
9 9
0.44 1945.45% 14 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
70 70
29.04 141.05% 12 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
110 110
73.14 50.4% 3 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
3.62 120.99% 14 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
44.45 34.98% 18 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
115 115
54.61 110.58% 20 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
33 33
8.99 267.07% 18 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
1.76 695.45% 11 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6 6
1.26 336.51% 6 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
0.78 1182.05% 12 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
n/a n/a 10 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
2.55 331.37% 11 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.96 155.1% 2 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
27 27
10.2 164.71% 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
0.72 31.94% 4 Aug 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
1 1
n/a n/a 11 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
7.49 46.86% 8 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
2 900% 1 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
n/a n/a 5 Mar 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12 23
n/a n/a 9 Jan 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
4.31 108.82% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28 32
n/a n/a 10 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
n/a n/a 12 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5
n/a n/a 6 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4
n/a n/a 3 May 15, 2023